Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: Thomson Reuters StreetEvents
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

STADA Arzneimittel AG Completes Acquisition of Thornton & Ross Ltd.

Friday, 16 Aug 2013 08:52am EDT 

STADA Arzneimittel AG announced that it has signed and concluded a contract for the purchase of Thornton & Ross Ltd., a British OTC manufacturer located in Huddersfield, after STADA and the owners had already announced contract negotiations on this issue on August 6, 2013. The purchase price amounts to GBP 221,117,910 (approximately EUR 259,223,810) in cash. This corresponds to GBP 193 million (approximately EUR 226 million) on a so-called cash and debt-free basis. Thornton & Ross has a number of prescription-free (OTC) branded products for a wide variety of indications - among other things, cold, pain and dermatology. Sales will presumably be consolidated in the STADA Group as of September 1, 2013. 

Company Quote

-0.27 -1.05%
11:35am EST